Vitamin D signaling is modulated on multiple levels in health and disease

Molecular and Cellular Endocrinology

Volumn 248, Issue 1-2, 2006, Pages 149-159

  Ebert, Regina ^a   Schütze, Norbert ^a   Adamski, Jerzy ^b   Jakob, Franz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

1 hydroxylase; Rickets; Vitamin D

Indexed keywords

ANDROGEN; CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; CYTOCHROME P450; ENZYME INHIBITOR; ESTROGEN; GENISTEIN; HETERODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR; OXYGENASE; PARATHYROID HORMONE; REGULATOR PROTEIN; RETINOID X RECEPTOR; SECOSTEROID; STEROID HORMONE ANTAGONIST; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

CALCIUM INTAKE; CHRONIC INFLAMMATION; CONFERENCE PAPER; DIETARY INTAKE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME LOCALIZATION; GENE CONTROL; HORMONE METABOLISM; HUMAN; KIDNEY METABOLISM; MALABSORPTION; NONHUMAN; NUTRITIONAL DEFICIENCY; OSTEOMALACIA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RICKETS; SIGNAL TRANSDUCTION; SUN EXPOSURE; TRANSACTIVATION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN D RESISTANT RICKETS; WASTING SYNDROME;

DNA; GENES; HEALTH; HUMANS; RECEPTORS, CALCITRIOL; RICKETS; SIGNAL TRANSDUCTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 33644895955     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.11.039     Document Type: Conference Paper

References (109)

1. J.S. Adams, H. Chen, R. Chun, M.A. Gacad, C. Encinas, S. Ren, L. Nguyen, S. Wu, M. Hewison, and J. Barsony Response element binding proteins and intracellular Vitamin D binding proteins: novel regulators of Vitamin D trafficking, action and metabolism J. Steroid Biochem. Mol. Biol. 89-90 1-5 2004 461 465
2. O.H. Al-Taie, J. Seufert, H. Mörk, H. Treis, B. Mentrup, A. Thalheimer, P. Starostik, J. Abel, M. Scheurlen, J. Köhrle, and F. Jakob A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency Eur. J. Hum. Genet. 10 9 2002 499 504
3. E.M. Awumey, D.A. Mitra, B.W. Hollis, R. Kumar, and N.H. Bell Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study J. Clin. Endocrinol. Metab. 83 1 1998 169 173
4. X.Y. Bai, D. Miao, D. Goltzman, and A.C. Karaplis The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency J. Biol. Chem. 278 11 2003 9843 9849
5. A.R. Baker, D.P. McDonnell, M. Hughes, T.M. Crisp, D.J. Mangelsdorf, M.R. Haussler, J.W. Pike, J. Shine, and B.W. O'Malley Cloning and expression of full-length cDNA encoding human Vitamin D receptor Proc. Natl. Acad. Sci. U.S.A. 85 10 1988 3294 3298
6. F. Barletta, P. Dhawan, and S. Christakos Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription Am. J. Physiol. Endocrinol. Metab. 286 4 2004 E598 E608
7. A. Benet-Pages, B. Lorenz-Depiereux, H. Zischka, K.E. White, M.J. Econs, and T.M. Strom FGF23 is processed by proprotein convertases but not by PHEX Bone 35 2 2004 455 462
8. A. Benet-Pages, P. Orlik, T.M. Strom, and B. Lorenz-Depiereux An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Hum. Mol. Genet. 14 3 2005 385 390
9. F. Bergeron, R. Leduc, and R. Day Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications J. Mol. Endocrinol. 24 1 2000 1 22
10. T. Berndt, T.A. Craig, A.E. Bowe, J. Vassiliadis, D. Reczek, R. Finnegan, S.M.J. De Beur, S.C. Schiavi, and R. Kumar Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent J. Clin. Invest. 112 2003 785 794
11. C.N. Bernstein, and W.D. Leslie The pathophysiology of bone disease in gastrointestinal disease Eur. J. Gastroenterol. Hepatol. 15 8 2003 857 864
12. H.A. Bischoff, H.B. Stahelin, W. Dick, R. Akos, M. Knecht, C. Salis, M. Nebiker, R. Theiler, M. Pfeifer, B. Begerow, R.A. Lew, and M. Conzelmann Effects of Vitamin D and calcium supplementation on falls: a randomized controlled trial J. Bone Miner. Res. 18 2 2003 343 351
13. L.O. Björn, and T. Wang Vitamin D in an ecological context Int. J. Circumpolar Health 59 1 2000 26 32
14. A.E. Bowe, R. Finnegan, S.M. Jan de Beur, J. Cho, M.A. Levine, R. Kumar, and S.C. Schiavi FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate Biochem. Biophys. Res. Commun. 284 4 2001 977 981
15. B.D. Boyan, D.D. Dean, V.L. Sylvia, and Z. Schwartz Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms Connect Tissue Res. 44 Suppl. 1 2003 130 135
16. L.A. Brame, K.E. White, and M.J. Econs Renal phosphate wasting disorders: clinical features and pathogenesis Semin. Nephrol. 24 1 2004 39 47
17. A.J. Brown Therapeutic uses of Vitamin D analogues Am. J. Kidney Dis. 38 5 Suppl. 5 2001 S3 S19
18. M.A. Brown, M.A. Haughton, S.F. Grant, A.S. Gunnell, N.K. Henderson, and J.A. Eisman Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and Vitamin D receptor genes J. Bone Miner. Res. 16 4 2001 758 764
19. M.T. Cantorna, Y. Zhu, M. Froicu, and A. Wittke Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system Am. J. Clin. Nutr. 80 6 Suppl. 2004 1717S 1720S
20. T.O. Carpenter, B.K. Ellis, K.L. Insogna, W.M. Philbrick, J. Sterpka, and R. Shimkets Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors J. Clin. Endocrinol. Metab. 90 2 2005 1012 1020
21. H. Chen, B. Hu, E.A. Allegretto, and J.S. Adams The Vitamin D response element-binding protein. A novel dominant-negative regulator of Vitamin D-directed transactivation J. Biol. Chem. 275 45 2000 35557 35564
22. H. Chen, M. Hewison, B. Hu, and J.S. Adams Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of Vitamin D resistance Proc. Natl. Acad. Sci. U.S.A. 100 10 2003 6109 6114
23. J.B. Cheng, M.A. Levine, N.H. Bell, D.J. Mangelsdorf, and D.W. Russell Genetic evidence that the human CYP2R1 enzyme is a key Vitamin D 25-hydroxylase Proc. Natl. Acad. Sci. U.S.A. 101 2004 7711 7715
24. 2-Vitamin D3 in Solanum glaucophyllum cultures grown in absence of light Biochim. Biophys. Acta 1425 3 1998 485 492
25. O. Dardenne, J. Prud'homme, A. Arabian, F.H. Glorieux, and R. St-Arnaud Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets Endocrinology 142 2001 3135 3141
26. O. Dardenne, J. Prud'homme, F.H. Glorieux, and R. St-Arnaud Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice J. Steroid Biochem. Mol. Biol. 89-90 1-5 2004 327 330
27. D. Deluca, A. Krazeisen, R. Breitling, C. Prehn, G. Moller, and J. Adamski Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes J. Steroid Biochem. Mol. Biol. 93 2-5 2002 285 292
28. M.K. Drezner PHEX gene and hypophosphatemia Kidney Int. 57 1 2000 9 18
29. 2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARg2) Exp. Gerontol. 39 2004 333 338
30. P.P. Dwivedi, C.S. Hii, A. Ferrante, J. Tan, C.J. Der, J.L. Omdahl, H.A. Morris, and B.K. May Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5 J. Biol. Chem. 277 33 2002 29643 29653
31. R. Ebert, M. Jovanovic, M. Ulmer, D. Schneider, J. Meißner-Weigl, J. Adamski, and F. Jakob Down-regulation by nuclear factor kappa B of human 25-hydroxyvitamin D3 1alpha-hydroxylase promoter Mol. Endocrinol. 18 10 2004 2440 2450
32. D.P. Edwards The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors J. Mammary Gland Biol. Neoplasia 5 3 2000 307 324
33. A. Enjuanes, N. Garcia-Giralt, A. Supervia, X. Nogues, L. Mellibovsky, J. Carbonell, D. Grinberg, S. Balcells, and A. Diez-Perez Regulation of CYP19 gene expression in primary human osteoblasts: effects of Vitamin D and other treatments Eur. J. Endocrinol. 148 5 2003 519 526
34. R.G. Erben, D.W. Soegiarto, K. Weber, U. Zeitz, M. Lieberherr, R. Gniadecki, G. Moller, J. Adamski, and R. Balling Deletion of deoxyribonucleic acid binding domain of the Vitamin D receptor abrogates genomic and nongenomic functions of Vitamin D Mol. Endocrinol. 16 7 2002 1524 1537
35. H. Farhan, and H.S. Cross Transcriptional inhibition of CYP24 by genistein Ann. N. Y. Acad. Sci. 973 2002 459 462
36. H. Farhan, K. Wahala, and H.S. Cross Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells J. Steroid Biochem. Mol. Biol. 84 4 2003 423 429
37. Glisson, F., 1650. De Rachitide sive morbo puerili, qui vulgo. The Rickets diciteur, London, pp. 1-416.
38. W.G. Goodman The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease Semin. Dial. 17 3 2004 209 216
39. R.P. Gupta, B.W. Hollis, S.B. Patel, K.S. Patrick, and N.H. Bell CYP3A4 is a human microsomal Vitamin D 25-hydroxylase J. Bone Miner. Res. 19 4 2004 680 688
40. M. Hewison, D. Zehnder, R. Chakraverty, and J.S. Adams Vitamin D and barrier function: a novel role for extra-renal 1alpha-hydroxylase Mol. Cell Endocrinol. 215 1-2 2004 31 38
41. J. Hilpert, L. Wogensen, T. Thykjaer, M. Wellner, U. Schlichting, T.F. Orntoft, S. Bachmann, A. Nykjaer, and T.E. Willnow Expression profiling confirms the role of endocytic receptor megalin in renal Vitamin D3 metabolism Kidney Int. 62 5 2002 1672 1681
42. A.B. Hittelman, D. Burakov, J.A. Iniguez-Lluhi, L.P. Freedman, and M.J. Garabedian Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins EMBO J. 18 19 1999 5380 5388
43. M.F. Holick Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis Am. J. Clin. Nutr. 79 3 2004 362 371
44. S. Ichikawa, K.W. Lyles, and M.J. Econs A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive J. Clin. Endocrinol. Metab. 90 4 2005 2420 2423
45. T. Jaaskelainen, S. Ryhanen, and P.H. Maenpaa 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both Vitamin D receptor and retinoid X receptor in human osteoblastic cells J. Cell Biochem. 89 6 2003 1164 1176
46. F. Jakob, F. Gieseler, A. Tresch, S. Hammer, J. Seufert, and D. Schneider Kinetics of nuclear translocation and turnover of the Vitamin D receptor in human HL60 leukemia cells and peripheral blood lymphocytes - coincident rise of DNA-relaxing activity in nuclear extracts J. Steroid Biochem. Mol. Biol. 42 1 1992 11 16
47. F. Jiang, P. Li, A.J. Fornace Jr., S.V. Nicosia, and W. Bai G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer J. Biol. Chem. 278 48 2003 48030 48040
48. P.W. Jurutka, G.K. Whitfield, J.C. Hsieh, P.D. Thompson, C.A. Haussler, and M.R. Haussler Molecular nature of the Vitamin D receptor and its role in regulation of gene expression Rev. Endocr. Metab. Disord. 2 2 2001 203 216
49. M. Kahraman, S. Sinishtaj, P.M. Dolan, T.W. Kensler, S. Peleg, U. Saha, S.S. Chuang, G. Bernstein, B. Korczak, and G.H. Posner Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3) J Med Chem. 47 27 2004 6854 6863
50. R. Lala, P. Matarazzo, M. Andreo, C. Defilippi, and C. de Sanctis Impact of endocrine hyperfunction and phosphate wasting on bone in McCune-Albright syndrome J. Pediatr. Endocrinol. Metab. 15 Suppl. 3 2003 913 920
51. T. Larsson, X. Yu, S.I. Davis, M.S. Draman, S.D. Mooney, M.J. Cullen, and K.E. White A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis J. Clin. Endocrinol. Metab. 90 4 2005 2424 2427
52. D. Lechner, and H.S. Cross Phytoestrogens and 17beta-estradiol influence Vitamin D metabolism and receptor expression-relevance for colon cancer prevention Recent Results Cancer Res. 164 2003 379 391
53. J.R. Leheste, F. Melsen, M. Wellner, P. Jansen, U. Schlichting, I. Renner-Muller, T.T. Andreassen, E. Wolf, S. Bachmann, A. Nykjaer, and T.E. Willnow Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect FASEB J. 17 2 2003 247 249
54. J.B. Lian, G.S. Stein, J.L. Stein, and A.J. van Wijnen Related Transcriptional control of osteoblast differentiation Biochem. Soc. Trans. 26 1 1998 14 21
55. C.J. Lin, A. Dardis, S.D. Wijesuriya, M.A. Abdullah, S.J. Casella, and W.L. Miller Lack of mutations in CYP2D6 and CYP27 in patients with apparent deficiency of Vitamin D 25-hydroxylase Mol. Genet. Metab. 80 4 2003 469 472
56. P. Lips Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr. Rev. 22 4 2001 477 501
57. S. Liu, R. Guo, L.G. Simpson, Z.S. Xiao, C.E. Burnham, and L.D. Quarles Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX J. Biol. Chem. 278 39 2003 37419 37426
58. Y.R. Lou, T. Murtola, and P. Tuohimaa Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells J. Steroid Biochem. Mol. Biol. 94 1-3 2005 151 157
59. L.A. Lyakh, M. Sanford, S. Chekol, H.A. Young, and A.B. Roberts TGF-beta and Vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells J. Immunol. 174 4 2004 2061 2070
60. P.N. MacDonald, T.A. Baudino, H. Tokumaru, D.R. Dowd, and C. Zhang Vitamin D receptor and nuclear receptor coactivators: crucial interactions in Vitamin D-mediated transcription Steroids 66 3-5 2001 171 176
61. P.N. MacDonald, D.R. Dowd, C. Zhang, and C. Gu Emerging insights into the coactivator role of NCoA62/SKIP in Vitamin D-mediated transcription J. Steroid Biochem. Mol. Biol. 89-90 1-5 2004 179 186
62. P.J. Malloy, and D. Feldman Hereditary 1,25-Dihydroxyvitamin D-resistant rickets Endocr. Dev. 6 2003 175 199
63. P.J. Malloy, R. Xu, L. Peng, P.A. Clark, and D. Feldman A novel mutation in helix 12 of the Vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia Mol. Endocrinol. 16 11 2002 2538 2546
64. V. Mann, E.E. Hobson, B. Li, T.L. Stewart, S.F. Grant, S.P. Robins, R.M. Aspden, and S.H. Ralston A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality J. Clin. Invest. 107 7 2001 899 907
65. S. Masuda, V. Byford, A. Arabian, Y. Sakai, M.B. Demay, R. St-Arnaud, and G. Jones Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1)null mouse Endocrinology 146 2 2005 825 834
66. A.G. Need, H.A. Morris, M. Horowitz, and C. Nordin Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D Am. J. Clin. Nutr. 58 6 1993 882 885
67. 2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells Proc. Natl. Acad. Sci. U.S.A. 101 19 2004 7392 7397
68. 2-Vitamin D3 Mol. Cell Endocrinol. 197 2002 1 13
69. A. Nykjaer, D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen, E.I. Christensen, and T.E. Willnow An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) Vitamin D3 Cell 96 4 1999 507 515
70. Y. Oda, C. Sihlbom, R.J. Chalkley, L. Huang, C. Rachez, C.P. Chang, A.L. Burlingame, L.P. Freedman, and D.D. Bikle Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in Vitamin D receptor transactivation during keratinocyte differentiation Mol. Endocrinol. 17 11 2003 2329 2339
71. Y. Ohyama, T. Kusada, T. Yamasaki, and H. Ide Extensive methylation of CpG island of CYP24 gene in osteoblastic ROS17/2.8 cells Nucleic Acids Res. Suppl. 2 2002 249 250
72. D.K. Panda, D. Miao, M.L. Tremblay, J. Sirois, R. Farookhi, G.N. Hendy, and D. Goltzman Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction Proc. Natl. Acad. Sci. U.S.A. 98 13 2001 7498 7503
73. D.K. Panda, D. Miao, I. Bolivar, J. Li, R. Huo, G.N. Hendy, and D. Goltzman Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and Vitamin D on skeletal and mineral homeostasis J. Biol. Chem. 279 16 2004 16754 16766
74. J.B. Peng, E.M. Brown, and M.A. Hediger Apical entry channels in calcium-transporting epithelia News Physiol. Sci. 18 2003 158 163
75. C. Rachez, B.D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A.M. Naar, H. Erdjument-Bromage, P. Tempst, and L.P. Freedman Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex Nature 398 6730 1999 824 828
76. M. Riminucci, M.T. Collins, N.S. Fedarko, N. Cherman, A. Corsi, K.E. White, S. Waguespack, A. Gupta, T. Hannon, M.J. Econs, P. Bianco, and P. Gehron Robey FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting J. Clin. Invest. 112 5 2003 683 692
77. F.F. Safadi, P. Thornton, H. Magiera, B.W. Hollis, M. Gentile, J.G. Haddad, S.A. Liebhaber, and N.E. Cooke Osteopathy and resistance to Vitamin D toxicity in mice null for Vitamin D binding protein J. Clin. Invest. 103 2 1999 239 251
78. S.C. Schiavi, and R. Kumar The phosphatonin pathway: new insights in phosphate homeostasis Kidney Int. 65 1 2004 1 14
79. J.M. Schlaeppi, S. Gutzwiller, G. Finkenzeller, and B. Fournier 1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells Endocr. Res. 23 3 1997 213 229
80. M. Schrader, J.P. Kahlen, and C. Carlberg Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter Biochem. Biophys. Res. Commun. 230 3 1997 646 651
81. I. Schuster, H. Egger, P. Nussbaumer, and R.T. Kroemer Inhibitors of Vitamin D hydroxylases: structure-activity relationships J. Cell Biochem. 88 2 2003 372 380
82. 2-Vitamin D3-responsive gene in human osteoblasts - regulation by selenite Biofactors 7 4 1998 299 310
83. J. Seufert, K. Ebert, J. Müller, J. Eulert, C. Hendrich, E. Werner, N. Schütze, G. Schulz, W. Kenn, H. Richtmann, K.D. Palitzsch, and F. Jakob Octreotide therapy for tumorinduced osteomalacia N Engl. J. Med. 345 26 2001 1883 1888
84. R. Shinkyo, T. Sakaki, M. Kamakura, M. Ohta, and K. Inouye Metabolism of Vitamin D by human microsomal CYP2R1 Biochem. Biophys. Res. Commun. 324 1 2004 451 457
85. W.D. Sierralta, F. Jakob, H. Thole, P. Engel, and P.W. Jungblut Estradiol-promoted accumulation of receptor in nuclei of porcine endometrium cells. Immunogold electron microscopy of resting and estradiol-stimulated cells Receptor 2 1 1992 29 37
86. L. Sinkkonen, M. Malinen, K. Saavalainen, S. Vaisanen, and C. Carlberg Regulation of the human cyclin C gene via multiple Vitamin D3-responsive regions in its promoter Nucleic Acids Res. 33 8 2005 2440 2451
87. R. St-Arnaud, A. Arabian, R. Travers, F. Barletta, M. Raval-Pandya, K. Chapin, J. Depovere, C. Mathieu, S. Christakos, M.B. Demay, and F.H. Glorieux Deficient mineralization of intramembranous bone in Vitamin D-24-hydroxylase- ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D Endocrinology 141 7 2000 2658 2666
88. R. St-Arnaud, O. Dardenne, J. Prud'homme, S.A. Hacking, and F.H. Glorieux Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1) J. Cell Biochem. 88 2 2003 245 251
89. T. Suda, Y. Ueno, K. Fujii, and T. Shinki Vitamin D and bone J. Cell Biochem. 88 2 2003 259 266
90. K. Tashiro, T. Abe, N. Oue, W. Yasui, and M. Ryoji Characterization of Vitamin D-mediated induction of the CYP 24 transcription Mol. Cell Endocrinol. 226 1-2 2004 27 32
91. The ADHR Consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat. Genet. 26 3 2000 345 348
92. M.K. Thomas, D.M. Lloyd-Jones, R.I. Thadhani, A.C. Shaw, D.J. Deraska, B.T. Kitch, E.C. Vamvakas, I.M. Dick, R.L. Prince, and J.S. Finkelstein Hypovitaminosis D in medical inpatients N. Engl. J. Med. 338 12 1998 777 783
93. P.D. Thompson, P.W. Jurutka, C.A. Haussler, G.K. Whitfield, and M.R. Haussler Heterodimeric DNA binding by the Vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions J. Biol. Chem. 273 14 1998 8483 8491
94. A. Toell, P. Polly, and C. Carlberg All natural DR3-type Vitamin D response elements show a similar functionality in vitro Biochem. J. 352 Pt 2 2000 301 309
95. A.G. Uitterlinden, Y. Fang, J.B. Van Meurs, H.A. Pols, and J.P. Van Leeuwen Genetics and biology of Vitamin D receptor polymorphisms Gene 338 2 2004 143 156
96. M. van Driel, H.A. Pols, and J.P. van Leeuwen Osteoblast differentiation and control by Vitamin D and Vitamin D metabolites Curr. Pharm. Des. 10 21 2004 2535 2555
97. B. Wharton, and N. Bishop Rickets Lancet 362 9393 2003 1389 1400
98. Whistler, D., 1645. Morbo puerili Anglorum, quem patrio idiomate indigenae vocant. The Rickets, Lugduni Batavorum, pp. 1-13.
99. P. White, and N. Cooke The multifunctional properties and characteristics of Vitamin D-binding protein Trends Endocrinol. Metab. 11 8 2000 320 327
100. C. White, E. Gardiner, and J. Eisman Tissue specific and Vitamin D responsive gene expression in bone Mol. Biol. Rep. 25 1 1998 45 61
101. K.E. White, G. Carn, B. Lorenz-Depiereux, A. Benet-Pages, T.M. Strom, and M.J. Econs Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23 Kidney Int. 60 6 2001 2079 2086
102. T.E. Willnow, and A. Nykjaer Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3 Curr. Opin. Lipidol. 13 3 2002 255 260
103. S. Wu, S. Ren, H. Chen, R.F. Chun, M.A. Gacad, and J.S. Adams Intracellular Vitamin D binding proteins: novel facilitators of Vitamin D-directed transactivation Mol. Endocrinol. 14 9 2000 1387 1397
104. S. Wu, R. Chun, M.A. Gacad, S. Ren, H. Chen, and J.S. Adams Regulation of 1,25-dihydroxyvitamin d synthesis by intracellular Vitamin D binding protein-1 Endocrinology 143 10 2002 4135
105. T. Yoshizawa, Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T. Kawakami, K. Arioka, H. Sato, Y. Uchiyama, S. Masushige, A. Fukamizu, T. Matsumoto, and S. Kato Mice lacking the Vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning Nat. Genet. 16 4 1997 391 396
106. D. Zehnder, and M. Hewison The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase Mol. Cell Endocrinol. 151 1-2 1999 213 220
107. D. Zehnder, R. Bland, E.A. Walker, A.R. Bradwell, A.J. Howie, M. Hewison, and P.M. Stewart Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney J. Am. Soc. Nephrol. 10 12 1999 2465 2473
108. D. Zehnder, R. Bland, R.S. Chana, D.C. Wheeler, A.J. Howie, M.C. Williams, P.M. Stewart, and M. Hewison Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion J. Am. Soc. Nephrol. 13 3 2002 621 629
109. C. Zierold, J.A. Mings, and H.F. DeLuca Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone J. Cell Biochem. 88 2 2003 234 237